Opinion|Videos|February 28, 2025
Older Approaches to Topical Treatment of Atopic Dermatitis
Author(s)Omar Noor, MD, FAAD, Randy Alevi, DO
Panelists discuss how older topical treatments such as corticosteroids, calcineurin inhibitors, and crisaborole have limited efficacy with prolonged use. Corticosteroids cause skin thinning and systemic absorption on large body surface area (BSA). Calcineurin inhibitors and crisaborole show modest efficacy, with application site reactions.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are some of the common uses as well as limitations of older topical treatment options (topical corticosteroids, calcineurin inhibitors, crisaborole)?
- Adverse effects, BSA limitations, long-term effects of steroids
- Discuss your approach to treatment for mild to moderate atopic dermatitis.
Advertisement
Related to this article
EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
Advertisement
Advertisement
Trending on Patient Care Online
1
Fezolinetant May Improve Depression, Anxiety Symptoms in Women With Menopausal VMS
2
Long-Acting Injectable HIV PrEP: Efficacy, Safety, and Injection Reactions
3
AI-Enhanced Virtual Reality Program Delivering CBT Shows Early Feasibility for Menopause Symptoms: TMS 2026
4
Menopause Hormone Therapy Linked to Greater Weight Loss With Semaglutide in Real-World Study
5